These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 26272385

  • 1. Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants.
    Ebner M, Peter A, Spencer C, Härtig F, Birschmann I, Kuhn J, Wolf M, Winter N, Russo F, Zuern CS, Blumenstock G, Ziemann U, Poli S.
    Stroke; 2015 Oct; 46(10):2741-7. PubMed ID: 26272385
    [Abstract] [Full Text] [Related]

  • 2. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M, Birschmann I, Peter A, Spencer C, Härtig F, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    Crit Care; 2017 Feb 15; 21(1):32. PubMed ID: 28196509
    [Abstract] [Full Text] [Related]

  • 3. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
    Ebner M, Birschmann I, Peter A, Härtig F, Spencer C, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    Stroke; 2017 Sep 15; 48(9):2457-2463. PubMed ID: 28775134
    [Abstract] [Full Text] [Related]

  • 4. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L, Lukes J, Friedecky D, Zhanelova M, Nemcova M, Ulehlova J, Prochazkova J, Hlusi A, Palova M, Vaclavik J.
    Clin Lab; 2018 Oct 01; 64(10):1611-1621. PubMed ID: 30336535
    [Abstract] [Full Text] [Related]

  • 5. Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.
    Harenberg J, Du S, Wehling M, Zolfaghari S, Weiss C, Krämer R, Walenga J.
    Clin Chem Lab Med; 2016 Feb 01; 54(2):275-83. PubMed ID: 26167981
    [Abstract] [Full Text] [Related]

  • 6. Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.
    Bluecher A, Meyer Dos Santos S, Ferreirós N, Labocha S, Meyer Dos Santos IM, Picard-Willems B, Harder S, Singer OC.
    Thromb Haemost; 2017 Feb 28; 117(3):519-528. PubMed ID: 28124061
    [Abstract] [Full Text] [Related]

  • 7. Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
    Eikelboom JW, Quinlan DJ, Hirsh J, Connolly SJ, Weitz JI.
    JAMA Cardiol; 2017 May 01; 2(5):566-574. PubMed ID: 28355459
    [Abstract] [Full Text] [Related]

  • 8. Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method.
    Du S, Harenberg J, Krämer S, Krämer R, Wehling M, Weiss C.
    Ther Drug Monit; 2015 Jun 01; 37(3):375-80. PubMed ID: 25525760
    [Abstract] [Full Text] [Related]

  • 9. Lupus-anticoagulant testing at NOAC trough levels.
    Ratzinger F, Lang M, Belik S, Jilma-Stohlawetz P, Schmetterer KG, Haslacher H, Perkmann T, Quehenberger P.
    Thromb Haemost; 2016 Aug 01; 116(2):235-40. PubMed ID: 27075441
    [Abstract] [Full Text] [Related]

  • 10. Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs).
    Padayattil Jose S, Banzato A, Carraro P, Haleh A, Rossi K, Nante G, Denas G, Zoppellaro G, Pengo V.
    Thromb Res; 2018 Mar 01; 163():100-104. PubMed ID: 29407620
    [Abstract] [Full Text] [Related]

  • 11. Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis.
    Ebner M, Birschmann I, Peter A, Härtig F, Spencer C, Kuhn J, Rupp A, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    J Am Heart Assoc; 2018 Oct 02; 7(19):e009807. PubMed ID: 30371316
    [Abstract] [Full Text] [Related]

  • 12. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
    Mani H, Herth N, Kasper A, Wendt T, Schuettfort G, Weil Y, Pfeilschifter W, Linnemann B, Herrmann E, Lindhoff-Last E.
    Ther Drug Monit; 2014 Oct 02; 36(5):624-31. PubMed ID: 24577124
    [Abstract] [Full Text] [Related]

  • 13. Anti-Xa Oral Anticoagulant Plasma Concentration Assay in Real Life: Rivaroxaban and Apixaban Quantification in Emergency With LMWH Calibrator.
    Billoir P, Barbay V, Joly LM, Fresel M, Chrétien MH, Le Cam Duchez V.
    Ann Pharmacother; 2019 Apr 02; 53(4):341-347. PubMed ID: 30378443
    [Abstract] [Full Text] [Related]

  • 14. Stability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment.
    McGrail R, Revsholm J, Nissen PH, Grove EL, Hvas AM.
    Thromb Res; 2016 Dec 02; 148():107-110. PubMed ID: 27835819
    [Abstract] [Full Text] [Related]

  • 15. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T, Flieder T, Fox V, Gripp T, Dittrich M, Kuhn J, Alban S, Knabbe C, Birschmann I.
    Eur J Cardiothorac Surg; 2017 Apr 01; 51(4):624-632. PubMed ID: 28043992
    [Abstract] [Full Text] [Related]

  • 16. Measuring Direct Oral Anticoagulants.
    Gosselin RC, Douxfils J.
    Methods Mol Biol; 2017 Apr 01; 1646():217-225. PubMed ID: 28804832
    [Abstract] [Full Text] [Related]

  • 17. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.
    Bliden KP, Chaudhary R, Mohammed N, Muresan AA, Lopez-Espina CG, Cohen E, Raviv G, Doubleday M, Zaman F, Mathew B, Tantry US, Gurbel PA.
    J Thromb Thrombolysis; 2017 May 01; 43(4):437-445. PubMed ID: 28247290
    [Abstract] [Full Text] [Related]

  • 18. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW, Barillari G.
    J Clin Pharm Ther; 2014 Apr 01; 39(2):118-35. PubMed ID: 24383983
    [Abstract] [Full Text] [Related]

  • 19. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
    Lagoutte-Renosi J, Le Poupon J, Girard A, Montange D, Davani S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov 15; 1100-1101():43-49. PubMed ID: 30292948
    [Abstract] [Full Text] [Related]

  • 20. Determination of dabigatran, rivaroxaban and apixaban by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS) and coagulation assays for therapy monitoring of novel direct oral anticoagulants.
    Schmitz EM, Boonen K, van den Heuvel DJ, van Dongen JL, Schellings MW, Emmen JM, van der Graaf F, Brunsveld L, van de Kerkhof D.
    J Thromb Haemost; 2014 Oct 15; 12(10):1636-46. PubMed ID: 25142183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.